May 23, 2024
Trinity Biotech Announces Q1 2024 Financial Results and Reiterates Guidance
DUBLIN, Ireland (May 23, 2024)… Trinity Biotech plc (Nasdaq: TRIB), a commercial stage
biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced the Company’s results for the quarter ended March 31, 2024.